[B018] Drug basic information

get
https://connect.patsnap.com/synapse/drug/detail
Try in Sandbox

Obtain drug basic information about drugs, including name, target, disease, active organization, etc.

Request Parameters

List of parameters supported by this API endpoint

NameTypeExampleDescription
drug_id
Required
string11d208e0c26a4345946d95f92d9fcaf0
Drug ID, obtain this through the drug search interface or drug autocomplete interface

Response Schema

Structure of the API response data

Field NameTypeExampleDescription
data
object-
response data
target
array[ { "target_id": "928facc8122849baa0dc00759cff0380", "short_name": [ { "lang": "EN", "name": "KRAS G12C" } ], "display_name": [ { "lang": "EN", "name": "GTPase KRas G12C" }, { "lang": "CN", "name": "KRAS G12C突变" } ] } ]
Target
hgnc_id
array[ "HGNC:12680" ]
List of HGNC IDs
mesh_id
array[ "7422" ]
List of MESH IDs
target_id
string1c2067e5ab054a8995f73efcfcf56207
Target ID
short_name
array[ { "lang": "EN", "name": "VEGF" } ]
Target Short Name, Referencing "CommonName"
lang
stringEN
Language
name
stringRanibizumab (Genentech)
Drug,Target,Organization,Disease,Country/Location,DICT,Mechanism Action Name
gene_symbol
array[ { "lang": "EN", "name": "VEGFA" } ]
Gene Symbol
display_name
array[ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ]
Target Full Name, Referencing "CommonName"
disease
array[ { "disease_id": "a0304a462da04e7cb03e3f2c5625544e", "display_name": [ { "lang": "EN", "name": "Advanced Lung Non-Small Cell Carcinoma" }, { "lang": "CN", "name": "晚期非小细胞肺癌" } ] } ]
Indication
umls
array[ "C0021368", "C0021364" ]
List of UMLS IDs
disease_id
string06a9082fe1ec4c97bea31d888b9cfdce
Disease ID
display_name
array[ { "lang": "EN", "name": "Uveitic Macular Edema" }, { "lang": "CN", "name": "葡萄膜炎黄斑水肿" } ]
Disease Name, Referencing "CommonName"
drug_id
string2838b95ade834c96b17ac8bcd2b68c27
Drug ID
dev_code
arrayPlease check the form: DrugDevCodeResponseDto
Dev code
code
stringJP 1366
Code
name
stringJP 1366
Name
status
stringACTIVE
Status
sequence
array[ { "chain_type": [ "L" ], "sequence_text": "DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC", "sequence_number": 43254 } ]
Sequence
chain_type
array[ "L" ]
Chain type
sequence_text
stringDILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
Sequence Text
sequence_number
integer<int64>43254
Sequence number
atc_codes
array[ "L01XE44" ]
ATC Code
drug_name
array[ { "lang": "CN", "name": "索托拉西布" }, { "lang": "EN", "name": "Sotorasib" }, { "lang": "JP", "name": "ソトラシブ" } ]
Drug Name
drug_type
array[ { "display_name": [ { "lang": "EN", "name": "Small molecule drug" }, { "lang": "CN", "name": "小分子化药" } ], "normalized_id": "1151dbc710f64a85923dc05d4a5a0ba9" } ]
Drug Type
display_name
array[ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ]
Dict Name
normalized_id
string2fbfdb3e92d942c48cbb0adb79f23526
Dict ID
structure
array[ { "base64": "data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ", "formula": "C30H30F2N6O3", "inchi_key": "NXQKSXLFSAEQCZ-SFHVURJKSA-N" } ]
Structure
base64
stringdata:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ
Image Base64
formula
stringC30H30F2N6O3
Molecular formula
inchi_key
stringNXQKSXLFSAEQCZ-SFHVURJKSA-N
inChiKey
canonical_smiles
stringCNC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O
canonicalSmiles
isometric_smiles
stringCNC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O
isometricSmiles
alias_name
array[ { "lang": "CN", "name": "索托雷塞" }, { "lang": "CN", "name": "索拖拉西布" } ]
Alias Name
exist_deal
booleantrue
exist a deal
trade_name
array[ { "name": "Lumakras" }, { "name": "Lumykras" }, { "name": "ルマケラス" } ]
Trade Name
generic_name
array[ { "lang": "CN", "name": "索托拉西布" }, { "lang": "EN", "name": "Sotorasib" }, { "lang": "JP", "name": "ソトラシブ" } ]
Generic Name
patent_mining
boolean-
Patent mining
milestone_tags
array[ { "date": "2023-05-01", "name": "First Phase 2 Clinical" }, { "date": "2023-06-15", "name": "First Phase 3 Clinical" } ]
Milestone Tags
date
integer<int64>1409788800000
milestone date
name
array[ { "lang": "EN", "name": "FDA Approval" }, { "lang": "CN", "name": "FDA批准" } ]
milestone name
approval_country
array[ { "country_id": "0dc5d896-7408-3c87-84c0-22e3d9b784be", "alpha2_code": "US", "display_name": [ { "lang": "EN", "name": "United States" }, { "lang": "CN", "name": "美国" } ] } ]
Approval Country/Location
country_id
string676de5ba-893a-36bb-8683-c93306aaf769
Country/Location ID
alpha2_code
stringUS
Alpha Code
display_name
array[ { "lang": "EN", "name": "United States" }, { "lang": "CN", "name": "美国" } ]
Country/Location Name
mechanism_action
array[ { "short_name": [ { "lang": "EN", "name": "KRAS G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C抑制剂" } ], "display_name": [ { "lang": "EN", "name": "GTPase KRas G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C突变抑制剂" } ], "mechanism_id": "27c0848a265e4332836e10d0e8202b4c" } ]
Mechanism
short_name
array[ { "lang": "EN", "name": "KRAS G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C抑制剂" } ]
Mechanism Action Short Name
display_name
array[ { "lang": "EN", "name": "GTPase KRas G12C inhibitors" }, { "lang": "CN", "name": "KRAS G12C突变抑制剂" } ]
Mechanism Action Name
mechanism_id
string27c0848a265e4332836e10d0e8202b4c
Mechanism Action ID
research_disease
array[ { "disease_id": "a0304a462da04e7cb03e3f2c5625544e", "display_name": [ { "lang": "EN", "name": "Advanced Lung Non-Small Cell Carcinoma" }, { "lang": "CN", "name": "晚期非小细胞肺癌" } ] } ]
Active Indication
special_approval
array[ { "country": { "country_id": "5a365096-b2a6-31cb-acdf-1de1f5ab3abe", "alpha2_code": "CN", "display_name": [ { "lang": "EN", "name": "China" }, { "lang": "CN", "name": "中国" } ] }, "special_view": { "display_name": [ { "lang": "EN", "name": "Breakthrough Therapy" }, { "lang": "CN", "name": "突破性疗法" } ], "normalized_id": "c3c948340a7d40f3b7437081f5e8cb4e" } } ]
Regulatory Review
country
object{ "country_id": "5a365096-b2a6-31cb-acdf-1de1f5ab3abe", "alpha2_code": "CN", "display_name": [ { "lang": "EN", "name": "China" }, { "lang": "CN", "name": "中国" } ] }
Country/Location
special_view
object{ "display_name": [ { "lang": "EN", "name": "Breakthrough Therapy" }, { "lang": "CN", "name": "突破性疗法" } ], "normalized_id": "c3c948340a7d40f3b7437081f5e8cb4e" }
Special Review
therapeutic_area
array[ { "disease_id": "62eaee6d9ee44410b8aca59dfc7408e9", "display_name": [ { "lang": "EN", "name": "Neoplasms" }, { "lang": "CN", "name": "肿瘤" } ] } ]
Therapeutic Areas
deal_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
Deal Organization
display_name
array[ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ]
Organization Name, Referencing "CommonName"
organization_id
string87bfaf037f8e60c9e25595cd98bb27e4
Organization ID
active_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
Active Organization
first_approval_date
integer<int64>1409788800000
First Approval Date
non_research_disease
array[ { "disease_id": "a1ddbb69fd3e46b6980bd4e1f1e64a45", "display_name": [ { "lang": "EN", "name": "Advanced Pancreatic Adenocarcinoma" }, { "lang": "CN", "name": "晚期胰腺腺癌" } ] } ]
Inactive Indication
highest_dev_status_cn
object{ "display_name": [ { "lang": "EN", "name": "Phase 3" }, { "lang": "CN", "name": "临床3期" } ], "normalized_id": "f835774c48404593b64ef05369eb8eba" }
Drug Highest Phase(China)
inactive_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
Inactive Organization
first_approval_date_cn
integer<int64>1532044800000
First Approval Date(China)
first_approved_country
array[ { "country_id": "52d1b118-b540-37ba-9cb2-f5aff686bb10", "alpha2_code": "KR", "display_name": [ { "lang": "EN", "name": "South Korea" }, { "lang": "CN", "name": "韩国" } ] } ]
First Approval Country/Location
first_approved_disease
array[ { "disease_id": "b3d498b086894c13bf5ac981a350af82", "display_name": [ { "lang": "EN", "name": "KRAS G12C mutant Non-small Cell Lung Cancer" }, { "lang": "CN", "name": "KRAS G12C突变非小细胞肺癌" } ] } ]
First Approval Disease
originator_organization
array[ { "display_name": [ { "lang": "EN", "name": "Amgen, Inc." }, { "lang": "CN", "name": "安进股份有限公司" } ], "organization_id": "11ef8a9e8bf5ca80213a1183511cded3" } ]
Originator Organization
global_highest_dev_status
object{ "display_name": [ { "lang": "EN", "name": "Approved" }, { "lang": "CN", "name": "批准上市" } ], "normalized_id": "efd6215835394b07b046125e3175d3fe" }
Drug Highest Phase
status
Required
booleanfalse
Status
error_msg
stringThe request parameter format is incorrect！
Error Message
error_code
Required
integer0
Error Code

Success Response Example

Example of a successful API response

JSON 
{
  "data": {
    "target": [
      {
        "hgnc_id": [
          "HGNC:12680"
        ],
        "mesh_id": [
          "7422"
        ],
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "gene_symbol": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "drug_id": "2838b95ade834c96b17ac8bcd2b68c27",
    "dev_code": [
      {
        "code": "JP 1366",
        "name": "JP 1366",
        "status": "ACTIVE"
      }
    ],
    "sequence": [
      {
        "chain_type": [
          "L"
        ],
        "sequence_text": "DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
        "sequence_number": 43254
      }
    ],
    "atc_codes": [
      "L01XE44"
    ],
    "drug_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "drug_type": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
      }
    ],
    "structure": [
      {
        "base64": "data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASwAAAEsCAYAAAB5fY51AAAAIGNIUk0AAHomAACAhAAA+gAAAIDoAAB1MAAA6mAAADqYAAAXcJy6UTwAAAAEZ0FNQQ",
        "formula": "C30H30F2N6O3",
        "inchi_key": "NXQKSXLFSAEQCZ-SFHVURJKSA-N",
        "canonical_smiles": "CNC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O",
        "isometric_smiles": "CNC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O"
      }
    ],
    "alias_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "exist_deal": true,
    "trade_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "generic_name": [
      {
        "lang": "EN",
        "name": "Ranibizumab (Genentech)"
      }
    ],
    "patent_mining": false,
    "milestone_tags": [
      {
        "date": 1409788800000,
        "name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "approval_country": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "mechanism_action": [
      {
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "mechanism_id": "27c0848a265e4332836e10d0e8202b4c"
      }
    ],
    "research_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "special_approval": [
      {
        "country": {
          "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
          "alpha2_code": "US",
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ]
        },
        "special_view": {
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ],
          "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
        }
      }
    ],
    "therapeutic_area": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "deal_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "active_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "first_approval_date": 1409788800000,
    "non_research_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "highest_dev_status_cn": {
      "display_name": [
        {
          "lang": "EN",
          "name": "Ranibizumab (Genentech)"
        }
      ],
      "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
    },
    "inactive_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "first_approval_date_cn": 1532044800000,
    "first_approved_country": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "first_approved_disease": [
      {
        "umls": [
          "C0021368",
          "C0021364"
        ],
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "originator_organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "global_highest_dev_status": {
      "display_name": [
        {
          "lang": "EN",
          "name": "Ranibizumab (Genentech)"
        }
      ],
      "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
    }
  },
  "status": true,
  "error_code": 0
}

Error Codes

List of possible error codes returned by this endpoint

Business Errors

Error CodeDescription
68300004Invalid parameter!
68300005Search api failure!
68300006Analytic basic access error!
68300007Bad request!
68300008Service error, please try again later!
68300010The file does not comply with upload specifications!

Platform Errors

Error CodeDescription
67200000API call exceeds the total limit set by the platform!
67200001API call exceeds the total limit set by the platform!
67200002The current call rate is too fast, exceeding the current configuration limit QPS!
67200003The key and secret parameters for applying for the token are incorrect or the client has been disabled!
67200004The requested api does not have permission. Please contact our support personnel!
67200005Insufficient account balance/number of calls!
67200006The client has exceeded the activation validity period!
67200007The current call exceeds the configured usage limit of the day!
67200008Please check if the required apikey in the query parameter has been transmitted!
67200009The apikey does not match the passed bearerToken. Please check if a valid token is being used!
67200012The request is illegal!
67200100The current server status is busy, request response timeout!
67200101The API requested currently does not exist. Please check the request path!

HTTP Status Codes

Status CodeDescription
0Success
401Unauthorized
403Forbidden
404Not Found